Is the Ebola Virus a Real Threat for Europe and the US?
Frost & Sullivan Life Sciences Senior Research Analyst Sriram Radhakrishnan discusses the available screening options to enable early detection of the virus
“The Zaire Ebola virus causes a highly contagious and lethal hemorrhagic fever leading to the death of the infected individuals. The recent outbreak of the virus in West Africa has alarmed the world, especially Europe and the US, owing to the geographical speed of the infection spread and high fatality rates.
While many experts feel that the chances of the spread of the virus are very low in Europe and the US, healthcare authorities have been on a high alert. As a result, airport security and hospitals have been aggressively preparing for checks of the disease spread.
In view of the high fatality rates caused by the Zaire Ebola virus, it has become increasingly important for healthcare authorities to adopt rapid and robust detection kits. Adoption of ELISA tests and RT-PCR sensitive tests will ensure faster detection of the virus and enable early administration of the therapy.
Hence, a fast and scalable supply of the ELISA and nucleic acid tests is needed to enable early detection. Further in the future, the spread of the virus, similar to that of influenza, should enable pharmaceutical markets to develop anti-Ebola viral therapies or perhaps even vaccines.”
Most read news
Other news from the department business & finance
These products might interest you
SepsiTest™-UMD CE IVD by Molzym
Make yourself independent: 16S/18S PCR for pathogen identification
Fast and precise detection of bacteria and fungi in blood/body fluids and tissue
Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation
Ksep® Consumable Kits by Sartorius
Ksep® Kits: Cell clarification and harvesting made easy
Automated solutions for higher yield and quality in bioprocessing
DNA/RNA Shield™ SafeCollect Collection Kits by Zymo Research
Sample collection devices for simple & safe at-home testing
Best user experience for secure self-collection
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.